China NMPA Drug Inspection - Pharmaceutical manufacturing and distribution enterprises in the jurisdiction - Antibiotics, imported drugs, etc. (a total of 77 batches were sampled)
China NMPA drug inspection for Pharmaceutical manufacturing and distribution enterprises in the jurisdiction published August 02, 2021. Drug: Antibiotics, imported drugs, etc. (a total of 77 batches were sampled). The Eighth Inspection Division of the Heilongjiang Provincial Drug Administration recently conducted a series of drug sa
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Pharmaceutical manufacturing and distribution enterprises in the jurisdiction published August 02, 2021. Drug: Antibiotics, imported drugs, etc. (a total of 77 batches were sampled). The Eighth Inspection Division of the Heilongjiang Provincial Drug Administration recently conducted a series of drug sa
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox